# Testing the Feasibility of Using Ropivacaine in Spinal Anesthesia for Patients With Lower Back Surgery

> **NCT05824338** · EARLY_PHASE1 · RECRUITING · sponsor: **Fraser Health** · enrollment: 45 (estimated)

## Conditions studied

- Anesthesia, Spinal
- Neurosurgery
- Ropivacaine
- Bupivacaine

## Interventions

- **DRUG:** Spinal anesthesia for lumbar surgery: ropivacaine
- **DRUG:** Spinal anesthesia for lumbar surgery: bupivacaine
- **DRUG:** General anesthesia for lumbar surgery

## Key facts

- **NCT ID:** NCT05824338
- **Lead sponsor:** Fraser Health
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-27
- **Primary completion:** 2025-07-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2024-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05824338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05824338, "Testing the Feasibility of Using Ropivacaine in Spinal Anesthesia for Patients With Lower Back Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05824338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*